enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Empagliflozin/linagliptin/metformin - Wikipedia

    en.wikipedia.org/wiki/Empagliflozin/linagliptin/...

    To reduce the risk of developing ketoacidosis (a serious condition where the body produces high levels of blood acids called ketones) after surgery, the FDA has approved changes to the prescribing information for SGLT2 inhibitor diabetes medications, recommending they be temporarily stopped before scheduled surgery.

  3. Empagliflozin - Wikipedia

    en.wikipedia.org/wiki/Empagliflozin

    The main efficacy measurement was the time to death from cardiovascular causes or need to be hospitalized for heart failure. [33] Of the individuals who received empagliflozin for an average of about two years, 14% died from cardiovascular causes or were hospitalized for heart failure, compared to 17% of the participants who received the ...

  4. Empagliflozin/linagliptin - Wikipedia

    en.wikipedia.org/wiki/Empagliflozin/linagliptin

    The most common side effects include urinary infections, nasopharyngitis, and upper respiratory tract infections . [5] [6] The most serious side effects include ketoacidosis (high blood levels of acids called ‘ketoacids’), pancreatitis (inflammation of the pancreas), hypersensitivity (allergic reactions) and hypoglycaemia (low blood sugar levels).

  5. Empagliflozin/metformin - Wikipedia

    en.wikipedia.org/wiki/Empagliflozin/metformin

    [6] [11] The extended release version was approved for use in the United States in December 2016. [ 12 ] [ 13 ] Empagliflozin/metformin was approved for use in Australia in May 2020.

  6. US obesity rates drop for 1st time in a decade, with possible ...

    www.aol.com/us-obesity-rates-drop-1st-160026522.html

    For the first time in over a decade, obesity rates in the United States may finally be heading in the right direction and new weight loss drugs like semaglutide could be part of the reason why. A ...

  7. Modified-release dosage - Wikipedia

    en.wikipedia.org/wiki/Modified-release_dosage

    Modified-release dosage is a mechanism that (in contrast to immediate-release dosage) delivers a drug with a delay after its administration (delayed-release dosage) or for a prolonged period of time (extended-release [ER, XR, XL] dosage) or to a specific target in the body (targeted-release dosage). [1]

  8. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    Empagliflozin, approved in the United States in August 2014, under the brand name Jardiance by Boehringer Ingelheim. [30] Of the gliflozins, empagliflozin and tofogliflozin have the highest specificity for SGLT2 inhibition. [1] This oral medicine for type 2 diabetes has been shown to reduce the risk of cardiovascular death. [31]

  9. AOL Mail

    mail.aol.com

    Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!